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1. Introduction
Congenital  aortic  stenosis  (AS)  is  caused  by  abnormal  morphological  development  of
the  aortic  valve.  [1,  2]  Valvular  abnormalities  may  be  accompanied  by  supra-  or  sub-
valvular  stenosis.  The  embryogenic  process  that  forms  aortic  valves  begins  approxi‐
mately  31–32  days  of  gestation.  Cavity  formation  in  the  basal  portion  of  the  truncus
arteriosus  is  a  key  process  in  the  development  of  the  leaflet  and  sinus  of  Valsalva,
which  are  important  components  of  the  aortic  valve.  Therefore,  incomplete  formation
of  the  cavity  causes  various  morphological  abnormalities  of  the  aortic  valve,  including
bicuspid  valve  with  or  without  commissural  fusion,  tricuspid  valve  with  commissural
fusion,  monocuspid  valve,  and  myxomatoid  leaflet  valve  (dysplastic  valve).  The  most
frequent  type  of  congenital  AS  is  a  bicuspid  aortic  valve,  [3]  accounting  for  approxi‐
mately 90% of  AS cases.
Although the  morphological  features  of  the  aortic  valve  are  closely  associated with  the
AS  severity,  the  pathophysiology  and  resultant  clinical  manifestation  of  AS  are  funda‐
mentally  determined  by  the  severity  of  the  stenosis  (effective  orifice  area).  In  this
sense,  congenital  AS  in  children  is  classified  into  2  major  types:  severe  AS  that  be‐
comes  symptomatic  and  necessitates  interventions  during  the  neonatal  period  or  early
infancy  and  a  milder  form  of  AS  with  signs  and/or  symptoms  that  develop  later  in
childhood.
In  this  chapter,  we  will  outline  the  pathophysiology,  clinical  characteristics,  and  man‐
agement  of  congenital  AS  observed  in  children  (from  fetus  to  adolescence)  for  each
type of  AS mentioned above.  We will  also  briefly  discuss  the  differences  in  ventricular
adaptation,  which  are  strongly  linked  to  the  clinical  manifestation  of  AS,  to  the  in‐
creased afterload caused by AS between children and adults.
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2. Pathophysiology of congenital AS
The mechanism underlying the increase in severity of AS in children is similar to that seen in
adults. The orifice size can decrease because of increased thickness and rigidity of the valve
leaflets, independent of the morphological anomalies of the aortic valve, although native
abnormal morphological features have greater impact on the progression of stenosis in
children than in adults. The mechanisms underlying the exacerbation of stenosis also need to
be determined. Valvular fibrosis, lipid accumulation, [4,5] inflammatory changes, [6] and
acquired fibrotic fusion of commissures, which increase cusp thickness/stiffness, [5,7] could
also be associated with the development of valvular stenosis, even in childhood AS. Metabolic
syndrome is an emerging issue even in children and may be associated with these exacerbating
mechanisms, [8] resulting in calcification, which reduces the possibility of valvular plastic
surgery. In addition, bicuspid aortic valves possibly develop aortic calcification earlier than
tricuspid aortic valves. [9,10] In this section, we will discuss the hemodynamic aspects of aortic
stenosis in fetuses, neonates, and children.
2.1. AS with signs and symptoms that develop during the fetal or neonatal period
The fundamental underlying pathophysiology of AS involves an increase in afterload to the
left ventricle (LV). The mechanism by which the LV copes with this increase in afterload is an
increase of myocardial mass (hypertrophy) to generate a higher force to confront the increased
afterload. If the aortic valve stenosis is too severe to allow the LV to become adaptive, LV
contractility is depressed and the LV becomes markedly dilated. In this critical condition, the
fetal circulation can maintain, to some extent, the systemic output using the right ventricle
(RV), because there are interatrial communication (foramen ovale) and ductus arteriosus in
the fetal ciculation. The ascending aortic flow and sometimes even the coronary arterial flow
rely on retrograde blood flow from the ductus arteriosus. However, an LV exposed to massive
afterload with relatively reduced coronary blood flow supply is at high risk of progressive
ventricular failure, and is associated with an increased risk of sudden cardiac death. If the
patient can survive this condition for a certain period, a marked increase in LV end-diastolic
pressure (EDP) hinders the blood flow from the left atrium entering into the LV, leading to a
gradual reduction of LV cavity volume. This process is postulated as one mechanism of
evolving hypoplastic left heart syndrome (HLHS). Degeneration of the endocardium may
accompany this process, representing a condition known as endocardial fibroelastosis. [11]
In other cases, an increase in LV afterload may allow the LV to exert its adaptive mechanism
of hypertrophy, which also inhibits LV inflow due to increased LV stiffness and resultant EDP
rise. [12] This is another form of evolving HLHS physiology (Figure 1A).
Of course, the above pathophysiological mechanisms should be understood as a continuum,
[13, 14] and some patients may be born with a markedly dilated LV and depressed contractility,
known as critical AS (Figure 1B). Such patients suffer from severe circulatory failure and
pulmonary congestion, which is often life threatening and requires emergency intervention,
either by catheters or surgery, as discussed below.
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Figure 1. A schema of hypoplastic left heart syndrome (A) and that of critical aortic stenosis (B).
2.2. AS with signs and/or symptoms that develop during late infancy and school age
When the severity of AS is mild such that the LV can cope with the increased afterload, patients
present with clinical symptoms during late infancy or school age. Although their LV exhibits
hypertrophy, AS may be mild enough in patients such that they will be asymptomatic. There are
also a group of patients who had no signs and symptoms other than heart murmur. In general,
the aortic valves of this group of patients can supply the systemic blood flow during the neona‐
tal period. This is verified by the fact that the ductus flow during the neonatal period shows left-
to-right shunting. The timing of the onset of AS symptoms in this group is dependent on the
severity of stenosis that is associated with the LV’s capability to exert its adaptive mechanism to
increased afterload. Of note, unlike adult onset AS, the severity of AS in children is also influ‐
enced by somatic growth, which induces a relative increase in the blood flow through the aortic
valve and thereby causes augmentation of LV afterload. In addition, it was reported that an in‐
creased pressure gradient across the aortic valve is related to earlier progression of stenosis and
a higher frequency of complicating aortic regurgitation. [15, 16] Therefore, the pathophysiology
of AS in this age group may be dependent on preload change due to aortic regurgitation as well
as the increasing afterload. In the clinical setting, it is important to follow-up with these patients
periodically to detect such changes and to determine the appropriate timing and method of
treatment. Therefore, we will discuss methods for monitoring the dynamic changes in AS in this
particular group of patients in the following section.
2.2.1. Monitoring methods for AS
Clinical symptom evaluation, physical examination, electrocardiogram (ECG), and echocar‐
diography are essential sources for obtaining comprehensive information for appropriate
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management of AS in this patient group. If fainting, convulsion, or resuscitated cardiac arrest
are observed, relieving AS is indicated for preventing further adverse events. [17, 18] Although
angina and syncope are reported to be observed only in <10% of patients whose peak-to-peak
pressure gradient is greater than 80 mmHg, chest pain is an important clinical sign indicating
the need for intervention, as adverse events are likely to occur within a few years after the
complaint of initial chest pain.
ECG examinations are informative if ST-segment changes are observed. Usually, severe AS
shows a 0–90°QRS-axis with high voltages in the left precordial leads. However, it is important
to note that the above ECG findings of LV hypertrophy do not necessarily reflect the severity
of the stenosis. Wagner et al. reported that one-third of AS patients with peak-to-peak pressure
gradients greater than 80 mmHg do not exhibit the above LV hypertrophic findings on ECG.
[17] In contrast, the ST strain pattern in the left precordial leads is thought to be more specific
to LV hypertrophy and reflects the severity of AS (Figure 2).
Figure 2. Electrocardiogram of severe aortic stenosis. This is an electrocardiogram (ECG) of a patient with severe aortic
stenosis with an estimated pressure gradient of 140mmHg. Surprisingly, ECG shows no prominent finding of left ven‐
tricular hypertrophy other than changes in ST-T segment.
Holter ECG is also useful for predicting sudden deaths, even in asymptomatic AS patients.
Wolfe et al. reported that multiform ventricular premature contraction, couplet, and ventric‐
ular tachycardia are serious arrhythmias that are associated with sudden cardiac death. [19]
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Exercise testing may provide more accurate information about the risk of cardiac events than
other examinations. Lewis et al. demonstrated the usefulness of exercise testing to identify sub‐
clinical ischemia in patients with severe AS. [26] Thus, exercise testing and Holter ECG may
play a key role in clinician decision making for the management of AS patients.
Echocardiography is a direct method for evaluating the anatomical features and severity of AS.
Valvular anatomy can be assessed for leaflet number, balance, thickening, or doming. The an‐
nulus diameter is also important, particularly when intervention is indicated. M-mode study in
short-axis view provides information regarding LV pressure calculated by Glanz’s equation:
LV systolic pressure=225*LVPWs/LVIDs, where LVPWs and LVIDs represent LV systolic pos‐
terior wall thickness and LV systolic diameter, respectively. [20] This equation is clinically use‐
ful, because the peak-to-peak pressure gradient can be evaluated when coupled with the
arterial pressure measurement. The LV dimension and wall thickness values provide informa‐
tion regarding the risk of cardiac events and ischemia. In addition, combining an echocardiog‐
raphy study with exercise testing may be useful for predicting a higher risk of cardiac events,
even in asymptomatic patients. [21] Velocity measurement by spectral pulse wave and continu‐
ous wave Doppler reflects the severity of AS if cardiac function is not impaired. The pressure
gradient calculated by applying the Bernoulli equation in the outflow tract is one of the guides
for determining the need for intervention, although it has some limitations. [22, 23] Spectral
pulse wave Doppler could also be a powerful tool for confirming the localization of obstruction
and estimating the valvular area.
The indication for the catheter examination is limited, but this modality provides accurate
information regarding coronary arteries and severity of AS. Because the LV outflow tract is
truncated, the severity of AS tends to be over-estimated by velocity-derived pressure gradient.
In contrast, a precise PIPG as well as a peak-to-peak gradient can be evaluated by the catheter
examination (Figure 3). The aortic valve area is also calculated by Gorlin’s method. [24]
Figure 3. Simultaneous measurements of ascending aortic pressure and left ventricular pressure by the catheter examina‐
tion. Both instantaneous and peak to peak pressure gradient can be clearly monitored. A; normal, B; aortic stenosis
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3. Treatment of AS
3.1. Fetal and neonatal AS
If the patients have an established HLHS circulation with an underdeveloped LV, all the
treatment options are directed to the future completion of the Fontan circulation, a final goal
for patients with single ventricular circulation. However, if the LV size and components are
to be sufficient to generate systemic output when the excessive afterload due to AS is relieved,
interventions for the aortic valve per se are indicated, including either catheters or surgery.
[25] The most attractive merit of catheter intervention (percutaneous transluminal aortic
valvuloplasty [PTAV]) is that it is less invasive. In this procedure, cardiopulmonary bypass,
which is a prerequisite for surgical procedures, can be avoided. PTAV is known to accelerate
annular growth even in small sized aortic valve [26] if mitral valve stenosis is not complicated
[27] .In performing PTAV, the carotid artery is generally used for blood access because lower
body hypoperfusion makes it difficult to achieve access from the femoral artery and has a high
risk of arterial obstruction with a prolonged sheath insertion, and because the curvature of
aortic arch makes it difficult to manipulate the catheter and successfully pass it through the
tiny aortic orifice (Figure 4). Therefore, central nervous system damage can be a potential
adverse event associated with PTAV. More importantly, PTAV is a procedure used to enlarge
the aortic orifice area by tearing the weak portions of the valve, not necessarily in the anatom‐
ically proper portion (commissures). Therefore, PTAV cannot be applied to valves with pre-
existing aortic regurgitation because the procedure generally worsens this condition, which
could be fatal. It was reported that 15% of 113 patients younger than 60 days old who had
undergone PTAV developed significant aortic regurgitation. [26] Surgical interventions in this
patient group include aortic valve plasty (AVP) and aortic valve replacement (AVR) with the
autologous pulmonary artery valve (Ross procedure). The advantage of open AVP is that
surgeons can perform the procedure on the basis of a detailed examination of the valve
anatomy, which may reduce the risk of aortic regurgitation. Bhabra et al. [28] reported that if
the aortic valve is tricuspid, the rate of freedom from reintervention after open AVP was 92%
and that of AVR was 100% at a 10-year follow-up. These rates for bicuspid valves were only
33% and 57%, respectively. This report emphasizes the importance of valve morphology as a
determinant of outcome following AVP. The other surgical option is the Ross procedure, which
is particularly useful when sub/suprastenosis coexists with valvular stenosis (Ross-Konno
procedure). The survival rate for the Ross procedure was 77% and rate of freedom from
reintervention was 50%, comparable to the results of the Norwood procedure. [29-31] To apply
the Ross procedure, autologous graft (pulmonary valve) function is important. Concha et al.
reported that the rate of freedom from autograft failure at a 5-year follow-up was 95%,
demonstrating a low incidence of autograft failure. [32] However, future pulmonary insuffi‐
ciency remains as a matter of concern in long-term follow-ups.
We often encounter intermediate cases between established HLHS with underdeveloped LV
and potentially normal-sized LV under excessive afterload. In such situations, accurate diag‐
nosis about whether the LV has the potential to generate systemic output after relieving af‐
terload is of primary importance. If the LV is judged to be incapable of generating systemic
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output, then the systemic circulation should rely on the RV. In such a case, the Fontan proce‐
dure becomes a goal of treatment. Multicenter studies have elucidated that the outcome of
biventricular repair with a small LV is much worse than that of the Fontan procedure [13,
14], although the survival rate of Fontan completion for patients with a small LV or severely
reduced LV function is only approximately 50-70%, even in the recent reports. [33-35]
Figure 4. Percutaneous transluminal aortic valvuloplasty performed for a patient with critical aortic stenosis
Based on the pathophysiology of evolving HLHS as previously discussed and the poor survival
rate of HLHS patients, fetal intervention has been attempted, aimed at relieving AS at earlier
stages before the LV cavity is reduced. For the first time, Maxwell et al. reported their experi‐
ence of intrauterine balloon dilatation of the fetal aortic valve in 1991. [36] Thereafter, a case
series of 12 fetuses that underwent balloon valvuloplasty in the third trimester were reported,
with no improvement was observed in their LV growth. [37] Tworetzky et al. also reported
the results of fetal intervention for 24 AS patients (ranging from 21 to 29 weeks of gestation)
who were thought to have a high probability of developing HLHS. [38] Technical success was
achieved in 14 patients, but only 3 patients were able to undergo two-ventricular repair.
Therefore, fetal intervention should be regarded as experimental at present, as many issues
remain to be solved.
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3.2. AS with signs and symptoms that develop during late infancy and school age
The treatment strategy for AS in which signs and/or symptoms develop later in childhood is
different from that for neonatal AS. The American College of Cardiology/American Heart
Association Guidelines for the management of AS of this group [31] recommended that
patients with a peak instantaneous pressure gradient (PIPG) measured by Doppler echocar‐
diography ≥70 mmHg be considered for cardiac catheterization and treatment in asympto‐
matic children and young adults. If the patients desire to participate in competitive sports or
become pregnant, a PIPG of 50–70 mmHg is an indication for further evaluation and inter‐
ventions. If patients have symptoms (angina, syncope, or dyspnea on exertion), a PIPG ≥50
mmHg is the indication for treatment. If the PIPG is less than 50 mmHg and a symptom is
present, another origin of the symptom should be investigated.
There are several treatment options for cases in which intervention is indicated, including
PTAV, open AVP, the Ross procedure, and AVR. Procedure selection is primarily dependent
upon whether the patient’s somatic size (aortic annular size) is large enough to use a prosthetic
valve, because AVR is considered as the first-line procedure at present. If the prosthetic valve
is not available, procedures other than AVR are selected so that patients can live with their
own valve until they can use a prosthetic aortic valve. In such situations, the most important
concept for treatment is that the procedure should be regarded as a bridge to AVR. Therefore,
the aim of any intervention should be to reduce the afterload without any significant aortic
regurgitation so that patients can grow uneventfully until AVR can be performed. In this sense,
if these patients do not have heart failure but have exertion-induced ischemic signs, restriction
of exercise without invasive intervention may be selected to achieve a better outcome.
Application of PTAV in this age group is relatively limited because AVP is thought to be better
than PTAV in terms of preserving aortic valve function, [39, 40] and because aortic insufficiency
caused by valvuloplasty is known to be progressive in nature. [15, 16] However, some patients
may still benefit from PTAV to achieve the therapeutic goal in this AS group. The Ross
procedure is also not regarded as a definitive repair surgery, because neoaortic regurgitation
and pulmonary insufficiency are frequently observed postoperative complications, which
require further interventions in the future. [40, 41] Therefore, the Ross procedure indication is
limited to patients who cannot grow due to severe aortic insufficiency.
4. The hemodynamic effects of AS on ventricular function in children
In this last section, we briefly comment on the differences in LV geometric and functional
changes between adult- and child-onset of AS. The natural history of LV geometric and
functional changes in adult-onset AS is characterized by LV concentric hypertrophy in the
early stage, followed by diastolic dysfunction, systolic dysfunction with eccentric hypertro‐
phy, and heart failure at the end-stage. [42] Most of the patients who are candidates for surgical
intervention are ranked in the state between diastolic and systolic ventricular dysfunction.
Delayed relaxation characterizes early-stage ventricular diastolic dysfunction, and thus is
observed in almost all AS patients, [43] while increased diastolic stiffness is observed in more
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advanced stages in which LV hypertrophy and fibrosis may coexist. The degree of diastolic
dysfunction is important for predicting prognosis because it takes years to achieve reverse
remodeling of diastolic function after normalization of afterload. [44]
In contrast to the relatively uniform geometric and functional LV changes observed in adult-
onset AS, such changes in children’s AS are diverse and somewhat different from those of
adults. The difference primarily stems from the diversity of the initial impact of afterload on
the LV. Because adult onset of AS is largely due to a bicuspid valve or atherosclerotic change
with aging, AS gradually increases LV afterload. This allows the LV to confront the increased
afterload by inducing hypertrophic changes. However, the severity of AS that initially imposes
afterload on the LV is diverse in children, as previously discussed, thus excessive afterload
may not allow the LV to become hypertrophic, resulting in LV dilation and systolic dysfunction
as observed in critical AS. With increasing age, the LV geometry and function gradually
resembles those of adult AS: a hypertrophic LV with diastolic dysfunction. However, it is rare
in children to observe a marked increase in LV diastolic stiffness, even in cases of hypertrophic
LV (Figure 5). In addition, it is interesting that LV relaxation appears to be relatively preserved
in children with AS and hypertrophic LV. These differences in LV functional responses
between children and adults may have a clue to a better management of patients with AS.
Figure 5. Examples of left ventricular pressure-volume relationships in a control patient (A) and a patient with aortic
stenosis (B). The steep slope of the end-systolic pressure-volume relationship (solid line) and arterial elastance (dashed
line) indicate increased ventricular contractility and afterload. Note that the slope of the end-diastolic pressure-vol‐
ume relationship in aortic stenosis is comparable to that of control.
5. Conclusions
In adults, AS generally develops slowly, with the progression of valve calcification or leaflet
degeneration being independent of the existence of substrates for congenital abnormalities.
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This allows the LV to adapt to the increased afterload by becoming concentrically hypertro‐
phied. Therefore, it takes a long time before LV systolic function is severely impaired and
critical events occur.45 Because valvular calcification is a commonly observed morphological
change and because a prosthetic valve is generally available for adults, aortic valve replace‐
ment is selected as a first-line treatment and plastic surgery is seldom chosen for this popula‐
tion. Thus, the treatment strategy is rather straightforward.
In contrast, as discussed in this chapter, a wide range of clinical phenotypes is seen in pediatric
AS. Depending on the severity of the native aortic valve abnormality and associated hemo‐
dynamic features, AS could be one of the most severe forms of congenital heart defects in
children, leading to a critical condition in neonates or even during fetal life. In the milder form
of pediatric AS, no clinical symptoms are seen throughout the patient’s life. Therefore, the
complexity of the treatment approach depends upon the patient’s age, body size, and associ‐
ated cardiac anomalies. In particular, because of the limited availability of prosthetic aortic
valves for small children, the native valve morphological features constitute an extremely
important determinant of treatment strategy. A detailed assessment of LV function as well as
accurate anatomical diagnosis, including analysis of the potential utility of the native aortic
valve, is essential for achieving a better outcome for patients. The use of specific medications
[46] and prevention of metabolic syndrome from childhood may help improve outcomes.
Accumulation of information regarding the outcomes of underdeveloped valves, detailed
mechanisms underlying disease progression, surgical outcomes, and improvements in surgical
techniques should lead to considerably improved outcomes in the pediatric population.
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